...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: TD Waterhouse-TFSA
1
Dec 13, 2017 06:50PM
1
Dec 14, 2017 05:15AM
5
Dec 15, 2017 09:00AM

I editted my post but it didn't add the following...

Hopefully, the information is contained in the Sedar and you should be able to follow up with your institution and the CRA - good luck.

Please Note:  This is not intended as investment advice - Please do your own due dilgence.  :)

Long

2
Dec 15, 2017 10:39AM
1
Dec 17, 2017 11:00AM

Dec 18, 2017 01:38PM
Share
New Message
Please login to post a reply